Tensions rise in Korea's pharma sector as Trump plans drug tariffs. Companies like Samsung Biologics monitor the situation ...

A wave of biosimilar approvals, aggressive pricing strategies, and a regulatory sea change are setting the stage for ...

Samsung Biologics, which has enjoyed a booming contract drug manufacturing streak over the past year, has inked another ...

Adma Biologics (ADMA) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance ...

Rival LG said it first, now Samsung says it might relocate manufacturing of its Visual Display and Digital Appliance business units. ”[We] plan to minimize the impact of tariffs by ...

Samsung Biologics, the biotech arm of Samsung Group, has secured its second contract manufacturing deal this year, signing a major agreement worth 737.3 billion won ($513 million) with a US-based ...

The positive opinions are based on applications submitted by Biosimilar Collaborations Ireland Limited, an indirect wholly owned subsidiary of Biocon Biologics Ltd. These recommendations follow a ...

The big picture: Gemini AI comes preinstalled on Samsung's latest mobile devices, and Google is paying a significant amount for that privilege. According to executives in Mountain View ...

Samsung Biologics' first-quarter revenue grew 37% to KRW 1.3 trillion, driven by higher contribution from the completion of Plant 4 in 2024, strong biosimilar sales, and favorable currency impact.

Table of Contents Latest Samsung Galaxy S26 leaks and rumors Samsung Galaxy S26: what we want to see When to expect the Galaxy S26 series It should come as no surprise that the list of Galaxy S26 ...

"We sustained solid momentum in the first quarter, supported by the efficient operations across all our plants and continued partnerships with our clients," said John Rim, CEO and President of Samsung ...